Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China

Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China

31 January 2024 | Xueru Yin, Wei Wang, Hui Chen, Qing Mao, Guorong Han, Lyufeng Yao, Qingwei Gao, Yunfei Gao, Jie Jin, Tong Sun, Minghua Qi, Hua Zhang, Baijun Li, Chongyang Duan, Fuqiang Cui, Weiming Tang, Polin Chan, Zhihua Liu, Jinlin Hou & SHIELD Study Group
The SHIELD program, a multicenter, multilevel intervention program in China, aimed to reduce mother-to-child transmission (MTCT) of hepatitis B virus (HBV). The study included 30,109 pregnant women from 178 hospitals and 8,642 pregnant women from 160 community-level health facilities. The overall MTCT rate was 0.23% in the implementation stage and 0.23% in the community scale-up stage. Compliance with interventions significantly reduced the MTCT rate, from 3.16% among noncompliant participants to 0.16% and 0.03% in the hospital and community settings, respectively. The program integrated antenatal HBsAg screening, antiviral treatment for high-risk mothers, timely administration of the hepatitis B vaccine and immunoglobulin, and routine follow-up for exposed infants. The findings demonstrate the feasibility and effectiveness of comprehensive interventions in reducing HBV MTCT, with implications for global elimination efforts.The SHIELD program, a multicenter, multilevel intervention program in China, aimed to reduce mother-to-child transmission (MTCT) of hepatitis B virus (HBV). The study included 30,109 pregnant women from 178 hospitals and 8,642 pregnant women from 160 community-level health facilities. The overall MTCT rate was 0.23% in the implementation stage and 0.23% in the community scale-up stage. Compliance with interventions significantly reduced the MTCT rate, from 3.16% among noncompliant participants to 0.16% and 0.03% in the hospital and community settings, respectively. The program integrated antenatal HBsAg screening, antiviral treatment for high-risk mothers, timely administration of the hepatitis B vaccine and immunoglobulin, and routine follow-up for exposed infants. The findings demonstrate the feasibility and effectiveness of comprehensive interventions in reducing HBV MTCT, with implications for global elimination efforts.
Reach us at info@study.space